| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6da44ae188083dd82975d6ed4611722c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2013-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f0c7f53168dca3def3b3001a4f57f9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfcce2040535969437c043ad57ef2468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44438a5d586b1af7ca7624b4a2646789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58acbee3d2ad8287f58ddfb13feacf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18086fc7c80ebf9910cedcec7692c3d4 |
| publicationDate |
2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2822955-A1 |
| titleOfInvention |
Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer |
| abstract |
The present disclosure relates to boron-based 4-hydroxytamoxifen and endoxifen prodrugs and the synthesis of the same. Further, the present disclosure teaches the utilization of the boron- based 4-hydroxytamoxifen and endoxifen prodrugs in a treatment for breast cancer. |
| priorityDate |
2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |